Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $306 Million - $376 Million
-2,101,948 Reduced 51.89%
1,948,733 $338 Million
Q1 2024

May 14, 2024

BUY
$165.67 - $199.94 $15 Million - $18.1 Million
90,330 Added 2.28%
4,050,681 $685 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $22.3 Million - $29.4 Million
-147,109 Reduced 3.58%
3,960,351 $782 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $11.8 Million - $13.6 Million
-70,325 Reduced 1.68%
4,107,460 $715 Million
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $4.2 Million - $4.86 Million
-26,074 Reduced 0.62%
4,177,785 $719 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $44.2 Million - $53.2 Million
303,796 Added 7.79%
4,203,859 $700 Million
Q4 2022

Feb 14, 2023

BUY
$131.14 - $157.47 $76.2 Million - $91.6 Million
581,411 Added 17.52%
3,900,063 $572 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $101,726 - $125,229
686 Added 0.02%
3,318,652 $492 Million
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $217,422 - $278,925
1,394 Added 0.04%
3,317,966 $570 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $272 Million - $350 Million
-1,497,105 Reduced 31.1%
3,316,572 $625 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $243,662 - $310,763
1,258 Added 0.03%
4,813,677 $1.17 Billion
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $281,852 - $312,228
-1,489 Reduced 0.03%
4,812,419 $934 Million
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $22.3 Million - $26.9 Million
-143,050 Reduced 2.89%
4,813,908 $897 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $31 Million - $36.5 Million
215,381 Added 4.54%
4,956,958 $781 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $4.91 Million - $5.45 Million
31,239 Added 0.66%
4,741,577 $785 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $37 Million - $44.6 Million
269,743 Added 6.07%
4,710,338 $779 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $91 Million - $116 Million
813,255 Added 22.42%
4,440,595 $609 Million
Q1 2020

May 15, 2020

BUY
$92.66 - $144.94 $134 Million - $209 Million
1,444,228 Added 66.15%
3,627,340 $427 Million
Q4 2019

Feb 18, 2020

BUY
$116.25 - $133.25 $254 Million - $291 Million
2,183,112 New
2,183,112 $289 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capital Research Global Investors Portfolio

Follow Capital Research Global Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.